Over the past few months, as we've watched trial results roll in about Pfizer and

Moderna, Johnson & Johnson, and AstraZeneca, we've become accustomed to seeing those results

as soon as they are computed.

Pfizer announcing early trial results in teens showing its vaccine is 100% effective.

Stunning early results from this trial from U.S. firm Moderna have eclips the strong ones

just a week ago from Pfizer.

Johnson & Johnson has announced trial results for the first single-dose coronavirus vaccine

with 66% efficacy.

The American company Novavac said that its vaccine was 89% effective in UK trials.

This may seem like common sense. It is not, however, necessarily common practice.

Farmer researchers are often negligent about timely reporting of trial outcomes.

As recently as five years ago, one prominent politician scolded the industry

over its transparency failures. There was a report in stat news that although NIH funding

for cancer trials requires the funding, when you get the funding, requires the results of that

data being reported instantly. The number of institutions

have received the most funding from NIH funding don't report back to NIH in a timely fashion,

sometimes a year or more. NIH scientists themselves, 75% of the time are late or don't report

their results.

Doc, I'm going to find out whether it's true.

And if it's true, I'm going to cut funding.

That's a promise.

That's a promise.

...